SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dick's Sporting Goods, Inc. engages in the retailing of an extensive assortment of authentic sports equipment, apparel, footwear, and accessories. It also offers its products both online and through mobile applications. The company was founded by Richard T. Stack in 1948 and is headquartered in Coraopolis, PA.

Dicks Sporting Goods, Inc.

DKS is trending after a historic post-earnings collapse triggered by soft athletic footwear demand, a guidance cut, and Foot Locker integration worries, which sparked a wave of analyst price-target cuts. Retail traders are fiercely split between calling the selloff an overreaction and bottom-fishing for a bounce, while others warn of further downside or bet on a short squeezekeeping sentiment paradoxically bullish despite the rout.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is surging on news of its exclusive global licensing deal for VEPPANU, the first FDA-approved PROTAC for ER+/HER2- breast cancer, acquired from Arvinas and Pfizer. The community is focused on the drug's blockbuster potential, heavy short interest, and the stock's perceived undervaluation despite the company being profitable with multiple commercial products.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is trending as the community highlights a wave of bullish analyst price target raises into earnings, which are expected to deliver a beat-and-raise. The narrative focuses on its valuation gap versus peers like CrowdStrike and constant speculation about a potential big-tech acquisition or strategic partnership.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is surging as a $1.55 billion U.S. government funding package for USA Rare Earth fuels a sector-wide rally in rare-earth and critical-minerals stocks, with retail traders on Stocktwits turning bullish and calling for a short squeeze on CRML's Greenland Tanbreez project.

Intuit, Inc. engages in the provision of business and financial management solutions. It operates through the following segments: Small Business and Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business and Self-Employed segment offers QuickBooks financial and business management online services and desktop software, payroll solutions, payment processing solutions, and financing for small businesses. The Consumer segment includes do-it-yourself and assisted TurboTax income tax preparation products and services. The Credit Karma segment serves consumers with a personal finance platform that provides personalized recommendations of credit cards, home, auto and personal loans, and insurance products, and online savings and checking accounts. The ProTax segment refers to the professional accountants in the U.S. and Canada, who are essential to both small business success and tax preparation and filing. The company was founded by Scott D. Cook and Thomas A. Proulx in March 1983 and is headquartered in Mountain View, CA.

Intuit Inc

Intuit is tumbling after its Q4 earnings beat was overshadowed by a weak FY2027 forecast, driven by a deliberate pivot to lower TurboTax pricing to counter AI-driven competition and customer churn. Retail sentiment on Stocktwits spiked to 'extremely bullish' despite the drop, with traders fiercely divided between seeing a buying opportunity and fearing deeper structural erosion from AI disruption.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SLS is trending as retail traders aggressively debate the imminent release of Phase 3 REGAL trial data for its lead cancer immunotherapy, with bulls anticipating a major value unlock or buyout while bears dispute the trial's design and patient population. The stock's price action remains highly volatile as the community fixates on the upcoming 

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Trading around Ginkgo Bioworks is being driven by the OpenAI-backed autonomous lab milestone and DARPA ICE Phase III progress, with bulls citing platform optionality and U.S. biosecurity tailwinds while bears highlight persistent cash burn and dilution concerns.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Traders are focused on Uber's push toward a key resistance level, with bullish sentiment tied to its expanding autonomous-vehicle partnerships, analyst support, and improving free-cash-flow generation. The broader debate centers on Uber's role in the robotaxi race against Waymo and Tesla, while a Dutch GDPR fine and driver complaints remain lingering concerns.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

$BW is trending as a BlackRock 13G filing revealed a 6.6% stake, fueling optimism around its AI data-center power contracts and short-squeeze potential. Community sentiment is splitsome see institutional validation and a turnaround, while others flag heavy manipulation, debt overhang, and frustration with price volatility.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is surging after reporting a second successful Phase 3 trial for its LSD-based anxiety treatment, which fueled a wave of bullish analyst price-target hikes and retail optimism about the drug's multi-billion-dollar commercial potential. The strong data cements Definium's leadership in the psychedelic sector and has traders anticipating further upside from upcoming trial readouts and an eventual NDA filing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UUUU, LEU, CCJ, BWXT Stocks In Focus: Trump’s Saudi Nuclear Push Reportedly Faces Congress Debate And Israel Hurdle

Centrus Energy is drawing intense trader attention as a U.S.-Saudi civilian nuclear pact moves to Congress, potentially unlocking a major enrichment market, while its new long-term supply deal with X-energy reinforces its role as America's only licensed HALEU producer. Social media sentiment highlights LEU's strategic position in the domestic fuel cycle and its exposure to AI-driven power demand, though some debate valuation and near-term price action.

UUUU, LEU, CCJ, BWXT Stocks In Focus: Trump’s Saudi Nuclear Push Reportedly Faces Congress Debate And Israel Hurdle 

Equity

Trump’s Saudi nuclear deal is now before Congress and could create new opportunities for U.S. companies involved in uranium, enrichment, reactors and nuclear fuel.


Can X-Energy's Xe-100 Capture the Growing Demand for Reliable AI Power?

XE's Xe-100 targets AI's growing power needs, backed by major customers and an 11.5-GW reactor pipeline.

Centrus Hosts Governor DeWine and JobsOhio at Piketon Uranium Enrichment Facility

Centrus Hosts Governor DeWine and JobsOhio at Piketon Uranium Enrichment Facility Centrus Hosts Governor DeWine and JobsOhio at Piketon Uranium Enrichment Facility PR Newswire PIKETON, Ohio, Aug. 24, 2026 Ohio's growing role in strengthening U.S. energy security, advanced manufacturing, and the...

Can X-Energy's Fuel Strategy Accelerate SMR Commercialization?

XE strengthens its fuel and supply-chain capabilities with HALEU and graphite agreements as it advances the Xe-100 toward commercialization.

CCJ's Adjusted EBITDA Fell 42% in Q226: Is There a Recovery Ahead?

Cameco's Q2 results weaken as lower uranium sales and Westinghouse earnings weigh on growth, but firm uranium prices support its longer-term outlook.

Is OKLO Stock Worth Buying Amid Rising Execution Risks?

Oklo's nuclear opportunity is expanding, but rising spending and execution risks cloud its path to recurring power revenues.

Should You Buy, Hold or Sell UUUU Stock Post Q2 Earnings?

Energy Fuels' uranium growth and rare earth expansion offer long-term potential, but a stretched valuation and expected 2026 loss weigh on its near-term appeal.

LEU Q2 Earnings Call Highlights Backlog and 2029 Build-Out

Centrus Energy highlights a $4.5B backlog, $900M DOE funding and a 2029 production goal as enrichment demand tightens and Piketon hiring accelerates.


LEU's Q2 Earnings Beat, Revenues up Y/Y on Strong Uranium Sales

Centrus Energy beats Q2 earnings and revenue estimates, but higher administrative and technology costs sharply compress margins.

Centrus Energy Signs LEU and HALEU Supply Agreement with X-energy

Centrus Energy Signs LEU and HALEU Supply Agreement with X-energy Centrus Energy Signs LEU and HALEU Supply Agreement with X-energy PR Newswire BETHESDA, Md., Aug. 6, 2026 Advances Commercialization for Domestic LEU and HALEU EnrichmentContract includes X-energy prepayments to CentrusPlanned...

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Bullish Sentiment

Rallies more than 5%

Modest gain (0-5%)

Modest decline (0-5%)

Drops more than 5%

Nvidia ($NVDA) reports earnings Wednesday, August 26, with options markets pricing in a roughly 5-7% post-earnings move. How do you think Nvidia's stock reacts to earnings? Vote and explain your reasoning in the comments.

Nvidia ($NVDA) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Stocktwits

) reports earnings Wednesday, with options markets pricing in a 5-7% move. How do you think the stock reacts?

Current Price	$193.39
Prev Close	$177.14
Open	$175.70
Dividend Yield	0.00%
50-Day Moving Average	$174.07
Beta	2.07
Avg. Volume	834,786.94
PE Ratio	88.24

52-Week High	$464.25
52-Week Low	$142.13
Market Capitalization	$3.53B
EPS (Annual)	$3.90
Price to Book	4.56
Revenue Per Employee	$960,813.70

Feed

News

Sentiment

Earnings

Fundamentals

Info